Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022)

Affiliations

• ¹ Department of Neuromuscular Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
• ² Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
• ³ NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK.
• ⁴ Department of Neurodegenerative Disease, Queen Square Institute of Neurology, UCL, London, UK.
• ⁵ The Perron Institute for Neurological and Translational Science, Perth, Australia.
• ⁶ The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
• ⁷ Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
• ⁸ Neurodegenerative Research Group, Mayo Clinic, Rochester, MN, USA.
• ⁹ Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, London, UK.
• ¹⁰ Neuroscience Research Australia, Sydney, Australia.
• ¹¹ School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.
• ¹² Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
• ¹³ Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
• ¹⁴ Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, Wakefield Street, London, UK.
• ¹⁵ Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
• ¹⁶ Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
• ¹⁷ Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, 00290, Helsinki, Finland.
• ¹⁸ Neuroscience CenterHiLife, University of Helsinki, 00290, Helsinki, Finland.
• ¹⁹ HUSlab, Helsinki University Hospital, 00290, Helsinki, Finland.
• ²⁰ Alzheimer's Disease and Other Cognitive Disorders Unit. Neurology Service, Hospital ClínicFundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomediques August Pi I Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.
• ²¹ Neurological Tissue Bank of the Hospital Clinic-IFRCB-IDIBAPS-Biobank, Barcelona, Spain.
• ²² Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Canada.
• ²³ Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
• ²⁴ Dementia Research Institute at UCL, Queen Square Institute of Neurology, UCL, London, UK.
• ²⁵ NIHR University College London Hospitals Biomedical Research Centre, London, UK.
• ²⁶ Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
• ²⁷ Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
• ²⁸ William Harvey Research Institute, Queen Mary University of London, London, UK.
• ²⁹ Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK. zhongbo.chen@ucl.ac.uk.
• ³⁰ NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK. zhongbo.chen@ucl.ac.uk.
• ³¹ Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, Queen Square House, London, WC1N 3BG, UK. zhongbo.chen@ucl.ac.uk.